Angiotensin Receptor Blockers (ARBs) Market Research Report 2022-2028 | Share, Global Trends, Key Players, Growth Analysis

The Angiotensin Receptor Blockers (ARBs) Market size is expected to grow at an annual average of 3% during 2022-2028. Angiotensin receptor blockers, also known as angiotensin receptor blockers, are primarily used to treat high blood pressure, diabetic nephropathy, and congestive heart failure. Angiotensin II receptor blockers are also used to treat patients with heart failure who are currently resistant to ACE inhibitor therapy. Angiotensin II receptor blockers have different efficacy with respect to blood pressure control, with statistically different effects at maximal doses, which may result in different degrees of response required.

The following segmentation are covered in this report:

By Application

• Hypertension
• Cardiovascular Diseases
• Kidney Diseases
• Other

By Product

• Valsartan
• Telmisartan
• Losartan
• Irbesartan
• Azilsartan
• Olmesartan

Company Profile

• Bristol-Myers Squibb
• Merck
• Bayer
• GSK
• Jhonson and Johnson
• Novartis
• Teva Pharmaceutical
• Sanofi
• Pfizer
• Astra Zeneca
• Eli Lilly

Scope of the report

The research study analyses the Angiotensin Receptor Blockers (ARBs) Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Angiotensin Receptor Blockers (ARBs) Market Report

• What was the Angiotensin Receptor Blockers (ARBs) Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Angiotensin Receptor Blockers (ARBs) Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.